6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9aR)-, acetate (1:1)
-
6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9aR)-, acetate (1:1)
structure -
-
CAS No:
10212-28-9
-
Formula:
C9H11N3O4.C2H4O2
-
Chemical Name:
6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9aR)-, acetate (1:1)
-
Synonyms:
6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R,3R,3aS,9aR)-,acetate (1:1);6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,[2R-(2α,3β,3aβ,9aβ)]-,monoacetate (salt);6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R,3R,3aS,9aR)-,monoacetate (salt);Cytosine,2,2′-anhydro-1-β-D-arabinofuranosyl-,monoacetate (salt);O-2,2′-Cyclocytidine monoacetate;Cyclocytidine acetate;NSC 129220
-
CAS No:
Description
Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.
6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9aR)-, acetate (1:1) Basic Attributes
285.25300
285.09608521 g/mol
129220
Drug Information
Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)
Ancitabine
Computed Properties
Molecular Weight:285.25
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:1
Exact Mass:285.09608521
Monoisotopic Mass:285.09608521
Topological Polar Surface Area:136
Heavy Atom Count:20
Complexity:425
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Request for Quotation